Concepedia

Matanel Yheskel

MY

8

Publications

781

Citations

8

H-Index

2015

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

University of Kansas Medical Center

Mayo Clinic

Regulus Therapeutics (United States)

Matanel Yheskel is an author at The University of Texas Southwestern Medical Center specializing in non-coding rna, cell development, and autoimmune disease.

ORCID

Top concepts

Publications per year

2015–2023

8

Publications

8

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism

Sachin Hajarnis, Ronak Lakhia, Matanel Yheskel et al. · Nature Communications · 2017 · 195 citations · Full text

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Edmund C. Lee, Tania Valencia, Charles Allerson et al. · Nature Communications · 2019 · 185 citations · Full text

PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice

Ronak Lakhia, Matanel Yheskel, Andrea Flaten et al. · American Journal of Physiology-Renal Physiology · 2017 · 134 citations · Full text

MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease

Ronak Lakhia, Sachin Hajarnis, Darren R. Williams et al. · Journal of the American Society of Nephrology · 2015 · 91 citations · Full text

Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression

Ronak Lakhia, Matanel Yheskel, Andrea Flaten et al. · JCI Insight · 2020 · 62 citations · Full text

, , +24

Rows per page

1–5 of 8